EEO-1 Reports Due March 31st
Client Alert | 1 min read | 03.14.18
As we enter the Ides of March, a reminder to all employers with 100 or more employees, and all government contractors/first-tier subcontractors with 50 or more employees and a contract of at least $50,000, that the 2017 EEO-1 report must be filed by March 31, 2018.
2017 revisions to the EEO-1 Report changed the annual filing date from September 30 to March 31, and would have required employers to submit compensation and hours data in addition to the standard workforce representation data. Employers received a reprieve from the compensation and hours data obligations in August 2017 when the Office of Management and Budget issued a stay of those portions of the revised Report. The change to the filing deadline, however, remained in place. As such, employers must now use a payroll period between October 1 and December 31, 2017 as the basis for the submission, and must file their 2017 EEO-1 Report by March 31, 2018.
So for those who were used to filing in the Fall, and may not have the filing date on their Spring calendars, don’t forget to submit by the March 31 deadline.
Contacts
Insights
Client Alert | 4 min read | 09.15.26
GAO Indicates Reasonable Conflict of Interest Investigation Must Include Inquiry of Involved Firm
The U.S. Government Accountability Office’s (GAO) recent decision in Viderity Inc.—Costs, B-424422.5, Sept. 1, 2026, offers useful insight into what constitutes a legally sufficient conflict of interest investigation. The decision arose in an unusual procedural posture: Viderity initially protested, alleging that an agency evaluator had a personal conflict of interest. After the agency took corrective action, Viderity filed a cost entitlement claim requesting that GAO direct the agency to reimburse Viderity’s protest costs. In evaluating that claim, GAO assessed whether Viderity’s underlying protest ground was “clearly meritorious.”
Client Alert | 3 min read | 09.15.26
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Client Alert | 6 min read | 09.14.26
Mental Health Parity Bulletin Restates Best Practices for Evaluating Compliance


